Related Experiment Video
Updated: Apr 14, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Subclinical myocardial injury in patients with insomnia symptoms and obstructive sleep apnea: A cross-sectional study
Athanasios Voulgaris1, Kostas Archontogeorgis1, Alexandros Kalkanis2
1MSc Program in Sleep Medicine, Medical School, Democritus University of Thrace, Alexandroupolis, Greece; Department of Pulmonology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Introduction:
Obstructive sleep apnea (OSA) is associated with cardiovascular disease (CVD). Emerging evidence suggests that OSA can lead to subclinical myocardial injury even in the absence of established CVD. We aimed to evaluate the burden of subclinical myocardial injury in patients with OSA and insomnia symptoms compared to patients with OSA only.
Methods:
Consecutive newly diagnosed patients with OSA and without pre-existing CVD were included in the study. All patients underwent polysomnography and completed the Athens Insomnia Scale (AIS). High- sensitivity troponin T (hs-cTnT) in the serum was measured in all participants for the evaluation of subclinical myocardial injury.
Results:
A total of 110 patients diagnosed with OSA (aged 54.9 ± 11.4 years) were divided into two groups according to the AIS score. Group A included 50 patients without insomnia symptoms (AIS score<6) and group B included 60 patients with insomnia symptoms (AIS score≥6). The two groups had similar OSA severity (apnea hypopnea index: 40.5 ± 24.2 for group A vs 38.9 ± 24.4 for group B; p = 0.721). Serum hs-cTnT levels were significantly elevated in group B compared to group A (11.1 ± 4.7 vs. 8.2 ± 4.7 pg/mL, respectively; p = 0.001). In linear regression analysis, serum hs-cTnT levels were associated with AIS score (β = 0.456, p = 0.001) and average nocturnal oxygen saturation (β = -0.807, p = 0.006).
Conclusions:
The present study revealed that patients with OSA and insomnia symptoms have a greater burden of subclinical myocardial injury compared to patients with OSA only.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Insomnia
Multiple factors contribute...
Management of Insomnia
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...